Lincocin Injection, Solution
Product Images NDC 0009-0107

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lincocin (NDC 0009-0107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lincocin 01)

FDA Label Image

Logo (Lincocin 02)

FDA Label Image

Principal Display Panel (1-2 mL Vial Label)

Principal Display Panel (1-2 mL Vial Label)
This text seems to be a product description for an injectable medication called Lincocin. The medication's dosage and usage directions are not given in this particular text, but are presumably available elsewhere. The medication is supplied in 1-2 mL vials and should be stored at a controlled temperature between 20° and 25°C. The text also mentions that the medication must be diluted before use and provides a National Drug Code (NDC) number for the product.*
FDA Label Image

Principal Display Panel (1-2 mL Vial Carton)

FDA Label Image

Lincocin 05

Lincocin 05
This appears to be a label or packaging information for an injectable medication named "Lincomycin". It is warned to be administered intravenously and must be used before the expiry date. The manufacturer appears to be "Pharmacia & Upjohn Co". The provided text does not provide further information.*
FDA Label Image

Lincocin 06

FDA Label Image

Lincocin 07

Lincocin 07
This is a description for Lincocin® which is a lincomycin injection used for intramuscular or intravenous purposes only. It needs to be stored at a controlled room temperature. The dosage and usage information can be found in the accompanying prescribing information. The warning advises to dilute it before intravenous use. Each mL of Lincocin injection contains 340 mg lincomycin hydrochioride USP, equivalent to 300 mg lincomycin, and 9.45 mg benzyl alcohol added as a preservative. Lincocin is a trademarked product by Pharmacia & Upjohn Co of Pfizer Inc, NY, NY 10017, and the NDC number is 0009-0107-04.*
FDA Label Image

Lincocin 08

Lincocin 08
Lincocin® lincomycin injection is intended for intramuscular or intravenous use. It contains lincomycin hydrochloride USP equivalent to 300 mg lincomycin and 9.45 mg benzyl alcohol added as a preservative. It is recommended to store it at a controlled room temperature of 20° to 25°C. Dosage and usage instructions are provided in the accompanying prescription information. Before intravenous use, caution must be exercised. The available imprint area suggests that copying or varnishing may not be necessary. *

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.